T he pathogenesis of atherosclerosis involves complex interactions among multiple risk factors. Because insulin resistance is usually seen in patients with multiple risk factors for atherosclerosis, such as hypertriglyceridemia, hypercholesterolemia, type 2 diabetes, and hypertension, it is difficult to evaluate whether insulin resistance directly induces atherosclerosis, even though it has been recognized as an independent risk factor for atherosclerosis. 1, 2 Transgenic and knockout mouse technology may provide useful models with which to dissect the contribution of insulin resistance to the pathogenic mechanisms that lead to atherosclerosis. [3] [4] [5] We previously generated two distinct murine models of insulin resistance: a representative murine model of insulin resistance and metabolic syndrome, that is, the insulin receptor substrate-1 deficient (IRS-1 Ϫ/Ϫ ) mouse, 6 and a representative murine model of insulin resistance and type 2 diabetes, that is, the insulin receptor substrate-2 deficient (IRS-2 Ϫ/Ϫ ) mouse. 7 However, the IRS-2 Ϫ/Ϫ mice display only insulin resistance without hyperglycemia until 8 to 10 weeks of age. We used a cuff-injured model that has a quantitative and reproducible end point. 8 In this model, external vascular cuff placement induces vascular neointima formation without the direct intraluminal injury that occurs, for example, with the balloon model, and this allows assessment of the effect of endothelial factors.
IRS-1 has been identified as a major substrate of both the insulin receptor and insulin-like growth factor-1 receptor tyrosine kinases. 9 The IRS-1 Ϫ/Ϫ mice have insulin resistance, hypertension, hypertriglyceridemia, and growth retardation 6,10,11 but fail to show type 2 diabetes as the result of compensatory ␤-cell hyperplasia and hyperinsulinemia. IRS-2 has been identified as an IRS-1-independent pathway for signal transduction of insulin, [12] [13] [14] and the IRS-2 Ϫ/Ϫ mice have insulin resistance and type 2 diabetes after 8 to 10 weeks of age as the result of a combination of insulin resistance and lack of compensatory ␤-cell hyperplasia. 7, 15 Thus, IRS-1 and IRS-2 play overlapping and distinct roles in the regulation of glucose homeostasis. 16 To determine the role of IRS-1 and IRS-2 in the development of atherosclerosis, we investigated whether IRS-1 Ϫ/Ϫ and IRS-2 Ϫ/Ϫ mice show abnormalities in neointima formation in response to vessel injury.
Methods

Animals
The IRS-1 Ϫ/Ϫ and IRS-2 Ϫ/Ϫ mice were maintained on the original C57BL6/CBA hybrid background. 6 The experiment in this study was performed on 8-and 20-week-old male mice. Femoral artery cuff (polyethylene tube; inner diameter, 0.58 mm; length, 2 mm) placement was performed as previously described, with some modifications. 8 Two weeks after cuff placement, femoral arteries were fixed in situ with 10% formalin and embedded in paraffin. Continuous cross sections (5 m) were then cut from one edge to the other edge of the cuffed portion. Morphometric analyses were performed on tissue stained for elastic fibers and with hematoxylin and eosin, as previously described, with some modifications. 8 The areas of lumen, intima, and media were measured in 10 cross sections, and the volume ratio of intima to media, intimal thickness, medial thickness, and luminal diameter were then calculated. The examiners of the sections were blinded to the genotype of the mice.
Antibody
Immunohistochemical staining was performed with an anti-␣ smooth muscle actin antibody (DAKO), anti-von Willebrand factor antibody (DAKO), anti-IRS-1 antibody (Santa Cruz Biotechnology, Inc), and anti-IRS-2 antibody (Santa Cruz Biotechnology, Inc).
Western Blot Analysis of the Aorta
For Western blot analysis, the aorta was rapidly excised and freed of surrounding fat and connective tissue. It was then homogenized, and samples were precipitated with anti-IRS-1 antibody (Upstate Biotechnology) or anti-IRS-2 antibody (Upstate Biotechnology) for 1 hour. Immunoprecipitated fractions were separated by 6% or 7.5% SDS-PAGE and transferred to PVDF membranes. Blots were first incubated with anti-IRS-1 antibody or anti-IRS-2 antibody for 1 hour at room temperature, and detection was performed by immunoblotting with the antibody.
Poly(A) ؉ RNA Preparation and RT-PCR
Poly (A) ϩ RNA extraction was performed by an mRNA kit (Invitrogen Co). RT-PCR was performed in accordance with standard practices, using poly (A) ϩ RNA from liver and artery. RT was performed for 50 minutes at 42°C with Super Script II (Invitrogen Co). RT-PCR was replicated a minimum of 5 times.
Blood Sample Assay
Fasting blood glucose was measured with an automatic glucometer (Glutest Ace, Sanwa Chemical Co). Plasma insulin (Shibayagi Co, Ltd), triglyceride, total cholesterol, free fatty acids, and HDL (Wako Pure Chemical Industries, Ltd) were assayed by enzymatic methods.
Measurement of Blood Pressure and Heart Rate
Systolic blood pressure and pulse rate were measured with an automatic sphygmomanometer by the tail-cuff method in unanesthetized animals.
Measurement of Isometric Force
The thoracic aorta of the IRS-1 Ϫ/Ϫ , IRS-2 Ϫ/Ϫ , and wild-type mice at 8 and 20 weeks was removed. It was placed in oxygenated and modified Krebs-Henseleit solution (KHS), as previously described. 18 The tissue was placed in a well-displacement transducer (TB-612T; Nihon-Kohden). The relaxation response to acetlycholine (ACh, Daiichi Pharmaceutical Co, Ltd) and sodium nitroprusside (SNP, Sigma Chemical Co) was expressed as percentage decrease in the tension of contractile force induced by PGF 2␣ (Ono Pharmaceutical Co, Ltd).
Statistical Analysis
Values are expressed as meanϮSEM. Statistical analyses were performed by ANOVA, and post hoc analysis was performed by the Bonferroni/Dunn method. Probability values of Յ0.05 were considered statistically significant.
Results
Increased Neointima Formation Is Induced by Vessel Injury in the IRS-2 ؊/؊ Mice
We placed a cuff around the femoral artery to induce inflammation of the adventitia and neointima formation. The 
IRS-1 ؊/؊ and IRS-2 ؊/؊ Mice Exhibit Hyperinsulinemia, Increased Free Fatty Acid, and Triglyceride Levels, and Hypertension
Blood glucose levels after a 16-hour fast did not differ significantly among the IRS-1 Ϫ/Ϫ , IRS-2 Ϫ/Ϫ , and wild-type mice at 8 weeks ( Figure 6A , a) but were significantly higher in the IRS-2 Ϫ/Ϫ mice than in the IRS-1 Ϫ/Ϫ or wild-type mice at 20 weeks, indicating that the IRS-2 Ϫ/Ϫ mice developed type 2 diabetes as previously described (Figure 6B, a) . 7 Plasma insulin levels were significantly higher in the IRS-1 Ϫ/Ϫ and IRS-2 Ϫ/Ϫ than in the wild-type mice at 8 and 20 weeks, indicating that the IRS-1 Ϫ/Ϫ and IRS-2 Ϫ/Ϫ mice were insulinresistant ( Figure 6A , b, and Figure 6B , b). Plasma free fatty acid levels were higher in the IRS-1 Ϫ/Ϫ and IRS-2 Ϫ/Ϫ mice than in the wild-type mice. However, they did not differ significantly between the IRS-1 Ϫ/Ϫ and IRS-2 Ϫ/Ϫ mice at 8 weeks ( Figure 6A, c) or among the IRS-1 Ϫ/Ϫ , IRS-2 Ϫ/Ϫ , and wild-type mice at 20 weeks ( Figure 6B, c) . Plasma triglyceride levels were significantly higher in the IRS-1 Ϫ/Ϫ and IRS-2 Ϫ/Ϫ mice than in the wild-type mice at 8 weeks ( Figure 6A , d) and were significantly higher in the IRS-2 Ϫ/Ϫ mice than in the wild-type mice at 20 weeks. In addition, they tended to be higher in the IRS-1 Ϫ/Ϫ mice than in the wild-type mice at 20 weeks ( Figure  6B, d) . Plasma total cholesterol levels were higher in the (Figure 7, a) , but at 20 weeks, the endotheliumdependent relaxation induced by ACh (10 Ϫ8 to 10 Ϫ5 mol/L) was significantly impaired in the IRS-2 Ϫ/Ϫ mice compared with the IRS-1 Ϫ/Ϫ or wild-type mice. The endotheliumdependent relaxation by ACh (10 Ϫ7.5 to 10 Ϫ7 mol/L) was also significantly impaired in the IRS-1 Ϫ/Ϫ mice compared with the wild-type mice (Figure 7, c) . By contrast, endotheliumindependent relaxation induced by SNP (10 Ϫ10 to 10 Ϫ5 mol/L) did not differ significantly among the IRS-1 Ϫ/Ϫ , IRS-2 Ϫ/Ϫ , and wild-type mice at 8 and 20 weeks (Figure 7, b and d) .
Discussion
In this study, we carried out cuff placement as an atherosclerotic model. This enabled us to quantify neointima formation reproducibly and differs from other atherosclerotic models, such as a filament model or a balloon injury model, 20 in several important ways. The latter two models involve removal of the endothelial layer, whereas in the cuff model, endothelial cells are not directly manipulated or removed, thereby allowing study of the effect of individual endothelial factors, as previously described. 8 We do not consider the mouse cuff model to be an ideal model of human atherosclerosis; however, we believe it to be close to the initial lesion of human atherosclerosis (type 1 lesion). Neointima formation mainly consists of cell components and does not include lipid deposition. It is a simple lesion but not a complex one. We believe cuff-induced neointima formation is associated with inflammation of the adventitia. This is not an exact model of restenosis after angioplasty because it avoids direct injury of endothelial cells. However, the restenosis after angioplasty is thought to be mainly due to an increased cell component rather than lipid deposition, and the cuff model can be investigated for a potential link between insulin resistance and restenosis after percutaneous coronary intervention. This is the first study to demonstrate that IRS-2 is protective against vascular neointima formation in response to vessel injury. At 8 weeks, although both IRS-1 Ϫ/Ϫ and Figure 6 . Comparison of risk factors for atherosclerosis. A, 8 weeks; B, 20 weeks; a, fasting blood glucose levels; b, fasting plasma insulin levels; c, fasting plasma free fatty acid levels; d, fasting plasma triglyceride levels; e, fasting plasma total cholesterol levels; f, fasting plasma HDL levels; g, systolic blood pressure; h, pulse rate. *PϽ0.05; **P<0.005; ***PϽ0.0001. mice is likely to be related to abnormalities induced by the altered metabolic milieu in insulin-resistant states. Nevertheless, we cannot completely exclude the possibility that IRS-2 has a direct protective effect on neointima formation because IRS-2 was much more abundantly expressed than IRS-1 in the vessels and IRS-2 expression tended to be lower at 20 weeks than at 8 weeks in the IRS-1 Ϫ/Ϫ mice. These findings collectively indicate that a lack of IRS-2 renders the vasculature more susceptible to injury in the abnormal metabolic milieu and that IRS-2 may have a protective effect on neointima formation.
Hypothesizing that the vascular endothelial cell dysfunction precedes the progression of atherosclerosis, we compared the endothelium-dependent vascular relaxation response among the IRS-1 Ϫ/Ϫ , IRS-2 Ϫ/Ϫ , and wild-type mice. The results showed that endothelium-dependent vascular relaxation was impaired in the IRS-2 Ϫ/Ϫ mice at 20 weeks but not at 8 weeks, when the neointima of the IRS-2 Ϫ/Ϫ mice began to be formed. There was mild impairment of endotheliumdependent vascular relaxation in the IRS-1 Ϫ/Ϫ mice at 20 weeks, even though the IRS-1 Ϫ/Ϫ mice did not show increased neointima formation at 8 weeks. On the basis of these observations, the endothelial cell dysfunction may not precede the formation of neointima, and it may be a consequence of the continued constellation of multiple risk factors rather than the lack of IRS-1 or IRS-2 in the vessels.
In summary, this study provides the first evidence that IRS-2 is protective and retards the development of neointima formation that occurs in response to vessel injury in insulinresistant states.
